Leptin restores cortical development in mice with KCNB1-linked disorder

A Rutgers-led study identifies a signalling partnership between leptin, KCNB1 channels and integrins that helps organise the developing cortex and reverses selected behavioural and structural defects in mutant mice.

Leptin has long been known as the body’s satiety signal, but a new study suggests its role begins far earlier, deep within the developing brain. Researchers led by Federico Sesti at Rutgers University have reported that the hormone is physically and functionally linked to a voltage-gated potassium channel called Kcnb1 and to integrins, the cell-adhesion proteins that help organise growing neurons. Published in iScience, the work proposes a tripartite signalling unit that connects metabolic cues with the machinery that shapes cortical development, offering a possible explanation for why disruptions in early nutrition and metabolism often travel with neurodevelopmental problems. The broader idea builds on earlier work from the same group showing that KCNB1 and the leptin receptor form stable complexes in hypothalamic neurons that control feeding and energy balance.

The study began with mice lacking functional Kcnb1 channels, a model relevant to the rare human disorder KCNB1-related developmental and epileptic encephalopathy. In those animals, the cortex develops abnormally: upper-layer neurons do not migrate properly, dendrites become overgrown, axon guidance is altered and behaviour is affected in ways that resemble attention-related difficulties seen in some children with the condition. The mice also show chronically low circulating leptin, or hypoleptinaemia, linked to hypothalamic dysfunction. That finding is consistent with previous research in the hypothalamus, where KCNB1-leptin receptor complexes were shown to regulate appetite, adipose tissue and pro-opiomelanocortin, or POMC, production during development.

To test whether leptin could influence brain development directly, the researchers used two approaches in newborn knockout mice: cross-fostering with wild-type mothers and direct leptin injections from birth through postnatal day 28. Both strategies restored circulating leptin without producing the weight loss that leptin can cause in other contexts. The effects were selective rather than global. Hyperactivity in an open-field test eased, but only in males. Nest-building improved in treated knockout mice, suggesting better motivation and goal-directed behaviour. Marble-burying, a measure of sensorimotor reactivity, improved more clearly with maternal cross-fostering than with injections, pointing to a meaningful maternal contribution. Wild-type mice were largely unchanged.

The hormone also improved several measures of learning and memory. In a Y-maze test of spatial working memory, leptin-treated knockout mice made fewer errors, with the strongest effect again seen in males. Novel object recognition improved as well, and the benefits were greater with injections than with cross-fostering. In the Barnes maze, the knockout mice already learned the escape location about as well as controls, but leptin increased exploratory behaviour and modestly sharpened retention. The pattern suggests that leptin does not indiscriminately correct every deficit; instead, it appears to normalise particular circuits and behaviours, while leaving typical animals mostly unaffected.

The anatomical rescue was more striking. Layers II through IV of the neocortex were thinner in the knockout mice, while the corpus callosum, especially splenial projections, was abnormally thick. Perinatal leptin treatment restored cortical thickness, corrected the enlarged commissural tract and improved the alignment of synapsin-1 and PSD-95, two markers of pre- and post-synaptic structure. The hormone also fixed a migration defect: neurons destined for the upper cortical layers were stranded in deeper layers in untreated knockouts, but leptin normalised their positioning. Further analysis showed that the hormone reduced excessive dendritic branching, restored spine density and shifted spines towards more mature forms.

At the cellular level, the mechanism appears to involve the actin cytoskeleton, the internal scaffold that helps neurons change shape and move. In cultured cortical neurons, leptin corrected abnormal dendritic growth in the knockout cells while leaving wild-type neurons largely unchanged. Fluorescence recovery experiments showed that actin dynamics were deranged in the mutant neurons and brought closer to normal by leptin. The researchers also found that aggregates of actin and the leptin receptor overlapped in cells carrying the pathogenic R312H KCNB1 variant reported in children with developmental and epileptic encephalopathy, hinting that the receptor may sit close to the heart of the structural problem.

Biochemical work then tied the pieces together. The team found leptin receptor transcripts in the upper cortical layers most affected by the mutation. Co-immunoprecipitation experiments showed that the leptin receptor associates with Kcnb1 and with integrins beta-1 and beta-5, and cross-linking studies supported those links. Pharmacology strengthened the case for a shared pathway: blocking the leptin receptor in wild-type neurons induced defects resembling the knockout state, while inhibiting integrins disrupted actin organisation and neuronal morphology. Conversely, fibronectin, an integrin ligand, helped restore the abnormal signalling seen in knockout neurons. The authors interpret these results as evidence that KCNB1, the leptin receptor and integrins converge on a common cytoskeletal programme.

The work also fits into a longer scientific arc. Classic studies first established leptin as a hormone secreted by adipose tissue that tells the brain when enough energy has been stored, while subsequent research showed that it can influence ion channels in hypothalamic neurons. More recent studies from Rutgers and elsewhere have extended that biology by showing that KCNB1-leptin receptor complexes are central to hypothalamic feeding circuits and normal energy homeostasis. The new cortical findings broaden that view, suggesting that leptin is not only a metabolic messenger but also a developmental signal that helps organise neuronal migration, dendritic growth, synapse formation and cognition.

The implications are potentially wide, though the authors are careful not to overstate them. They note that the hypothalamic and cortical roles of the complex are not necessarily identical, that glial cells were not addressed and that the exact architecture of the protein complex still needs to be mapped. Even so, the study offers a compelling framework for understanding why altered leptin states during pregnancy and early life may be linked to neurodevelopmental disorders. It also raises the possibility that carefully targeting leptin signalling in vulnerable infants could one day help address the brain effects of rare channel disorders and perhaps the consequences of maternal obesity, a major and modifiable risk factor.